NCT03983369View on ClinicalTrials.gov

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults

PHASE3RecruitingINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

August 29, 2018

Primary Completion Date

August 28, 2026

Study Completion Date

September 30, 2026

Conditions
Mucositis Oral
Interventions
DEVICE

Low-Level Laser Therapy

The LLL used is the K-Laser Cube 3. The LLL is an athermal laser beam of low power, equipped with a placebo function (dummy imitating beam laser light, emitted by the same device but without physiological effect).

OTHER

Placebo

Placebo

Trial Locations (5)

35203

RECRUITING

CHU de Rennes, Rennes

59020

RECRUITING

Centre Oscar Lambret, Lille

75019

RECRUITING

Hôpital Robert Debré, Paris

75248

RECRUITING

Institut Curie, Paris

94805

RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER